India's Commitment to Affordable Medicines for Rare Diseases
During the Rare Diseases Conference 2025, Union Secretary Shri Amit Agrawal emphasized the need for India to lead in providing affordable medicines for rare diseases. He highlighted the inclusion of rare diseases in the Production Linked Incentive (PLI) Scheme, which has significantly reduced treatment costs for several conditions. Agrawal called for collaboration among government, industry, and civil society to address the challenges faced by patients and caregivers, advocating for inclusivity in healthcare policies and practices.
Source: Original Link